An Open-label Study of APX001 for Treatment of Patients With Candidemia/Invasive Candidiasis Caused by Candida Auris
Conditions: Candidemia; Invasive Candidiases; Candida Infection Intervention: Drug: APX001 Sponsor: Amplyx Pharmaceuticals Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 1, 2019 Category: Research Source Type: clinical trials
Molecular Characterization of Candida Auris
Condition: Oral Fungal Infection Intervention: Other: No intervention Sponsor: Islamia University of Bahawalpur Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 10, 2019 Category: Research Source Type: clinical trials